feed,title,long_url,short_url
Investors,AI Stock Gets Neutral Rating Amid Microsoft Deal With Earnings Due,https://www.investors.com/news/technology/ai-stock-neutral-rating-c3ai-earnings/,https://da.gd/E9ObZ
Investors,The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market,https://www.investors.com/news/technology/eli-lilly-stock-weight-loss-drugs-compounded-semaglutide-tirzepatide/,https://da.gd/8NoSg
